Recombinant Human AP2A2, His-tagged
Cat.No. : | AP2A2-3532H |
Product Overview : | AP-2 complex subunit alpha-2 (AP2A2) |
- Specification
- Gene Information
- Related Products
- Download
Source : | E. Coli or Yeast |
Species : | Human |
Tag : | His |
Form : | This item requires custom production and lead time is between 5-9 weeks. We can custom produce according to your specifications. |
Protein length : | 940 |
Purity : | >90% |
Notes : | Small volumes of AP2A2 recombinant protein may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice. |
Storage : | Store at -20 degree C. For extended storage, store at -20 or -80 degree C. |
Storage Buffer : | PBS pH 7.4, 50% glycerol |
Warning : | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Gene Name : | AP2A2 adaptor-related protein complex 2, alpha 2 subunit [ Homo sapiens ] |
Official Symbol : | AP2A2 |
Synonyms : | AP2A2; adaptor-related protein complex 2, alpha 2 subunit; ADTAB, CLAPA2; AP-2 complex subunit alpha-2; adaptin; alpha B; alpha adaptin C; Huntingtin interacting protein J; clathrin associated/assembly/adaptor protein; large; alpha 2; DKFZP564D1864; HIP9; HYPJ; KIAA0899; alpha2-adaptin; adaptin, alpha B; huntingtin yeast partner J; 100 kDa coated vesicle protein C; huntingtin-interacting protein 9; alpha-adaptin C; Huntingtin interacting protein J; clathrin assembly protein complex 2 alpha-C large chain; plasma membrane adaptor HA2/AP2 adaptin alpha C subunit; clathrin-associated/assembly/adaptor protein, large, alpha 2; ADTAB; HIP-9; CLAPA2; FLJ37177; |
Gene ID : | 161 |
mRNA Refseq : | NM_001242837 |
Protein Refseq : | NP_001229766 |
MIM : | 607242 |
UniProt ID : | O94973 |
Chromosome Location : | 11p15.5 |
Pathway : | Axon guidance, organism-specific biosystem; Developmental Biology, organism-specific biosystem; Disease, organism-specific biosystem; EGFR downregulation, organism-specific biosystem; Endocrine and other factor-regulated calcium reabsorption, organism-spe |
Function : | lipid binding; molecular_function; protein transporter activity; |
Products Types
◆ Recombinant Protein | ||
AP2A2-601M | Recombinant Mouse AP2A2 Protein, His (Fc)-Avi-tagged | +Inquiry |
AP2A2-9715H | Recombinant Human AP2A2, His-tagged | +Inquiry |
AP2A2-1739M | Recombinant Mouse AP2A2 Protein | +Inquiry |
Ap2a2-3531R | Recombinant Rat Ap2a2, His-tagged | +Inquiry |
AP2A2-2111C | Recombinant Chicken AP2A2 | +Inquiry |
◆ Lysates | ||
AP2A2-8816HCL | Recombinant Human AP2A2 293 Cell Lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Reviews
- Q&As
Customer Reviews (4)
Write a reviewThe sensitivity of AP2A2 in Western blot is very high, and low concentrations of the target protein can be detected.
I appreciate the production process of AP2A2, every step is strictly controlled to ensure the quality and repeatability of the product.
Under different pH conditions, the stability of this protein is still very good, indicating that it has excellent acid-base stability.
AP2A2 are structurally stable and not prone to mutation.
Q&As (19)
Ask a questionRecombinant AP2A2 may play an antitumor role by inhibiting tumor growth and promoting autoimmunity.
Normally, AP2A2 injections should be stored in the refrigerator at a temperature of 2-8 ° C.
Recombinant AP2A2 therapy can be administered intravenously or intramuscularly.
Generally, the preparation methods of AP2A2 include recombinant DNA technology and protein expression and purification technology.
At present, the recombinant AP2A2 protein is still in clinical trials, and researchers are evaluating its safety and efficacy.
There are no clear studies showing that the AP2A2 improves patients' quality of life, but its therapeutic effect may vary for individuals.
Recombinant AP2A2 protein may regulate immune cell activity and enhance immune response, but the specific mechanism still needs to be further studied.
While some studies have shown that recombinant AP2A2 has a preventive effect, more research is needed to confirm its effectiveness.
The study of AP2A2 still faces challenges in terms of safety, efficacy and stability.
Although some preliminary studies suggest that recombinant AP2A2 may have a therapeutic effect on autoimmune diseases, more clinical trials are needed to determine its efficacy.
Evaluation of the effectiveness of AP2A2 therapy usually includes clinical symptom improvement, biomarker level detection, etc.
No definite side effects have been reported, but please consult your doctor before receiving treatment.
The indication for the treatment of AP2A2 needs to be determined based on the specific disease and individual patient situation. Consult your doctor for more accurate advice.
The duration of treatment for AP2A2 varies according to the purpose of treatment and individual differences, please consult your doctor for details.
Currently, the AP2A2 shows potential in the treatment of certain cancers and autoimmune diseases.
There is no clear clinical limit to its use, but different diseases and individual conditions may affect its therapeutic effectiveness.
There are no clear studies showing that recombinant AP2A2 has a therapeutic effect on non-immune-related diseases.
Recombinant protein AP2A2 is mainly involved in intracellular material transport and endocytosis.
Some studies have shown that recombinant AP2A2 can inhibit the growth and spread of certain cancer cells, but further clinical studies are needed to verify its therapeutic effect.
Ask a Question for All AP2A2 Products
Required fields are marked with *
My Review for All AP2A2 Products
Required fields are marked with *
Inquiry Basket